electroCore (ECOR) Stock Forecast: StockMap's 2-Week Call
ECOR stock forecast: StockMap's model leans Underperform on electroCore for the two weeks after the Nov 13 close, toward ECOR trailing the growth index. It is a lean inside the no-call band, not a call, and not a price target. Right in 2 of 3 two-week windows on ECOR since Sep 24; by chance, a call on the same dates was right 53% of the time.
electroCore last closed at $5.25, -0.76% on the session.
Against the IVW growth benchmark the position is +0.15% over the forecast window.
electroCore's market cap is $48.43M as of November 13, 2026.
Leans down ↘: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -33 (too close to call).
Where ECOR sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 4 bullish and 11 bearish.
Agreement across those insights is 73%.
18 daily calls for ECOR so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks electroCore in the 98th percentile on return on equity, where 100 is best.
electroCore is classified under Health Care / Health Care Equipment & Supplies.
StockMap tracks electroCore as the 113th largest of the 142 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.
Across that group the current two-week reads are 74 Neutral, 52 Moderate Underperform, 13 Strong Underperform and 3 Moderate Outperform.
On that composite electroCore ranks 103rd of 142 in the group, against a group median of -0.15.